Alaunos Therapeutics, Inc. · NASDAQ:TCRT
Fairmount Funds Management LLC reported a 19.99% stake in Alaunos Therapeutics, Inc. (Schedule 13D)
Event Oct 13, 2026 · Filed Oct 15, 2026
Fairmount Funds Management LLC reported a 19.99% stake in Alaunos Therapeutics, Inc., 858,789 shares, with active intent on Oct 13, 2026. Filed Oct 15, 2026 (Schedule 13D).
- Stake
- 19.99%
- Shares
- 858,789
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Fairmount Funds Management LLC | 19.99% | 858,789 |
| Fairmount Healthcare Fund II L.P. | 3.98% | 171,000 |
| Fairmount Healthcare Co-Invest VII L.P. | 19.99% | 858,789 |
| Harwin Peter Evan | 19.99% | 858,789 |
| Kiselak Tomas | 19.99% | 858,789 |
Source
Download original · View original at SEC